Injective Labs, a leading Web3 research and development company, has recently signed a five-year lease at 28&7 with Corem AB and GDS Development Management. The full-floor lease of 8,685 square feet at the SOM-designed building marks another milestone in the growing presence of Web3 companies, institutional finance firms, creative agencies and media companies within GDSNY properties throughout New York City.
Located in the heart of the Penn District on the corner of 28th Street and Seventh Avenue, Injective Labs will join other innovative tenants in this new class-A office building. With its focus on creating cutting-edge infrastructure for their blockchain platform Injective – optimized for financial applications – Injective Labs is an ideal fit for this forward-thinking property.
“We are thrilled to announce yet another exciting addition to our tenant roster,” said Michael Kirchmann CEO at GDSNY. “The high level of leasing activity we have seen speaks volumes about our commitment to providing top-notch spaces that cater specifically to finance & technology firms.”
Represented by Cushman & Wakefield’s Ethan Silverstein, Michael Movshovich Grant Potter,and Connor Daugstrup , ownership was pleased with their latest tenant acquisition. Steven Evans from Platinum Properties represented Injective Labs during negotiations.
This new lease further solidifies 28&7’s reputation as a premier destination for businesses operating within industries such as finance,m edia,and technology across Manhattan.
